The invention relates to certain amino-pyrimidine compounds which inhibit TBK1 and/or IKK epsilon and which may therefore find application in treating inflammation, cancer, septic shock and/or Primary open Angle Glaucoma (POAG).
这项发明涉及抑制TBK1和/或IKK epsilon的某些
氨基嘧啶化合物,因此可能在治疗炎症、癌症、感染性休克和/或原发性开角青光眼(P
OAG)中找到应用。